Literature DB >> 9770576

Inhaled nitric oxide therapy in a critically ill neonate with Ebstein's anomaly.

E Bruckheimer1, Z Bulbul, E Pinter, M Gailani, C S Kleinman, J T Fahey.   

Abstract

The successful use of nitric oxide (NO) inhalation in a critically ill neonate with Ebstein's anomaly of the tricuspid valve is reported for the first time. This use of inhaled NO therapy suggests a therapeutic intervention that directly addresses the pathophysiologic process of severe neonatal Ebstein's anomaly.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9770576     DOI： 10.1007/s002469900362

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  4 in total

Review 1.  Midterm result of a case after Starnes operation.

Authors:  Iki Adachi; Toru Ishizaka; Hajime Ichikawa; Koji Kagisaki; Shigetoyo Kogaki; Hikaru Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-05

2.  A novel approach incorporating sildenafil in the management of symptomatic neonates with Ebstein's anomaly.

Authors:  Phat Pham; Andrew Hoyer; Robin Shaughnessy; Yuk M Law
Journal:  Pediatr Cardiol       Date:  2006-08-01       Impact factor: 1.655

3.  Ebstein's anomaly of the tricuspid valve.

Authors:  Michelle Gurvitz; Karen Stout
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

4.  [Ebstein's anomaly revealed by fetal-placental anasarca. Original case study].

Authors:  Hanaa El Hadraoui; Amina Barkat
Journal:  Pan Afr Med J       Date:  2016-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.